Pharmaceuticals

  • Hoffmann-La Roche Limited

    Diamond Sponsor

    Focus: Psychiatric disorders, Neurodegenerative disorders, Neurodevelopmental disorders

    Roche is a leader in the research and development of pharmaceutical and diagnostic solutions that look beyond today’s horizons and make a profound difference in people’s lives.

    See Our Booth
  • Novartis Pharmaceuticals Canada Inc.

    Diamond Sponsor

    Focus: Neurology – Multiple Sclerosis, Migraine

    Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians.

    See Our Booth
  • Alexion Pharma Canada

    Gold Sponsor

    Focus: Child Neurology – Epilepsy, Migraine, SMA, Neonatal conditions

    Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies.

    See Our Booth
  • Alnylam Pharmaceuticals Canada

    Gold Sponsor

    Focus: Neurology – Hereditary TTR Amyloidosis, Acute Hepatic Porphyria

    Alnylam is the leading RNAi therapeutics company. We believe our efforts have the potential to improve the lives of Canadian rare disease patients.

    See Our Booth
  • Mitsubishi Tanabe Pharma Canada Inc.

    Gold Sponsor

    Focus: ALS (Amyotrophic lateral sclerosis)

    Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is focused on providing therapies for some of the most difficult-to-treat diseases. We strive to make a difference for those struggling with devastating illnesses.

    See Our Booth
  • Eli Lilly Canada Inc.

    Silver Sponsor

    Focus: Neurology – Migraine

    Eli Lilly and Company is a global health care leader that unites caring with discovery to make life better for people around the world.

    See Our Booth
  • BioMarin Pharmaceutical Inc.

    Exhibitor

    Focus: Child Neurology - late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) and other rare genetic diseases

    BioMarin provides innovative therapeutics to patients with serious unmet medical needs.

    See Our Booth
  • Eisai Limited

    Exhibitor

    Focus: Epilepsy, dementia related diseases and neurodegenerative diseases.

    Eisai Limited (pronounced ā-zī) is the Canadian pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd. Eisai is a human health care (hhc) company seeking innovative solutions in disease prevention, treatment and care for the health and well-being of people worldwide.

    See Our Booth
  • Medexus Pharmaceuticals

    Exhibitor

    Focus: Medexus Pharmaceuticals has a keen interest in fluorescence – guided resection

    Medexus Pharmaceuticals, Inc. is a rapidly growing, commercial-stage specialty pharmaceutical company with an established presence across North America that is focused on an array of therapeutic areas, including specialty oncology, rheumatology and auto-immune disease.

    See Our Booth
  • Sunovion Pharmaceuticals Canada Inc.

    Exhibitor

    Focus: Neurology – Partial onset seizures - Epilepsy. Child Neurology – Partial onset seizures - Epilepsy

    Sunovion Pharmaceuticals Canada Inc. (SPCI) is an innovative and entrepreneurial health care company that commercializes Sunovion’s prescription products in Canada. Focused in the areas of psychiatry, neurology and infectious disease, SPCI is committed to improving patient’s lives.

    See Our Booth